• Subscriptions
  • Contact
Documenta Haematologica - Revista Romana de Hematologie
  • About Us
  • Editorial Board
  • Current Issue
  • Archive
    • 2023 Volume 1
      • Issue 1
      • Issue 2
      • Issue 3
      • Issue 4
    • 2024 Volume 2
      • Issue 1
      • Issue 2
      • Issue 3
      • Issue 4
    • 2025 Volume 3
      • 2025, Volume 3, Issue 1
      • 2025, Volume 3, Issue 2
      • 2025, Volume 3, Issue 3
      • 2025, Volume 3, Issue 4
    • 2026 Volume 4
      • 2026, Volume 4, Issue 1
      • 2026, Volume 4, Issue 2
  • Editorial Process & Peer Review
  • Ethics and Rights
  • How To Submit
Select Page

ACMG-Based Reclassification of TP53 Variants in Oncogenetic Practice

by Catalin | Jun 26, 2026 | 2026 vol. 4 Issue 2

ACMG-Based Reclassification of TP53 Variants in Oncogenetic Practice Elena BULANCEA, Stefania IORDACHE, Cerasela JARDAN, Onda-Tabita CALUGARU Introduction: Variants of uncertain significance (VUS) in cancer predisposition genes, such as TP53, represent a major...
Next Entries »

Recent Posts

  • Nitric Oxide, Tumor Necrosis Factor-α, and Lipid Peroxidation as Biomarkers of Endothelial Injury in Sickle Cell Disease
  • When the Eyes Speak: A Multisystem Challenge with CNS and Orbital Spread Light Chain Myeloma
  • Unmasking VEXAS Syndrome: A Diagnostic Dilemma
  • TP53-Mutated Myelodysplastic Syndrome with Bone Marrow Fibrosis in a Young Adult: A Rare Diagnostic and Therapeutic Challenge
  • Kimura Disease – Not Every Lymphadenopathy is Malignant

Recent Comments

  1. A WordPress Commenter on Hello world!

Copyright © 2025 | Edited by Romanian Society of Hematology